Understanding FDA Regulations, Co-research and investment For clinical tests of new drug development between Korea and the U.S.

Drug Development Processes & Regulatory Approaches Seminar, University of Maryland School of Pharmacy (Natalie Eddington, Dean) Cheonbuk University Clinical Trial Center will be in Bio Park Establishment of generic factories: GLP Lab and GMP

1 Week Concentrated Education for U.S. FDA New Drug Development (32 people completed from Dong-A, Greencross, Dae-Woong, Hanall, and Celltrion) Cheonbuk University Clinical Trial Center will be in Bio Park, Maryland Neodin, MediTox, Maxgen, Dong-A R&D Center, and SAMIN Science Co., Ltd. are preparing to enter in the State of Maryland Participated International Bio Expo Chicago (Training program agreed with Gangwon Chuncheon Bio and Seoul)

1 Week Concentrated Education for U.S. FDA New Drug Development (32 people completed from Dong-A, Greencross, Dae-Woong, Hanall, and Celltrion) Cheonbuk University Clinical Trial Center will be in Bio Park, Maryland Neodin, MediTox, Maxgen, Dong-A R&D Center, and SAMIN Science Co., Ltd. are preparing to enter in the State of Maryland Participated International Bio Expo Chicago (Training program agreed with Gangwon Chuncheon Bio and Seoul)

The 3rd Korea-Maryland, USA Bio Expo 2013 (John McDounhough, Secretary presents Wonro Lee, CEO of JGBLI with a State Citation) SAMIN Science Co., Ltd. in the Center of Business Incubator, Maryland(Hyo Chul Chang, President) Cooperation between Jeonnam Korean Traditional Medicine Center and University of Maryland in Baltimore Center for integrative Medicine (Brian Berman, Professor) Supervised MOU between Jeollanamdo (Joon Yung Park, Governor) and the State of Maryland (Martin O'Malley, Governor) Supervised MOU between Jeollanamdo(Joon Yung Park, Governor) and Maryland Bio Park (James Hughes, President)